Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-262033
Filing Date
2025-11-03
Accepted
2025-11-03 11:40:38
Documents
14
Period of Report
2025-11-03

Document Format Files

Seq Description Document Type Size
1 6-K d852107d6k.htm 6-K 12939
2 EX-1.1 d852107dex11.htm EX-1.1 241040
3 EX-4.1 d852107dex41.htm EX-4.1 411441
4 EX-4.2 d852107dex42.htm EX-4.2 72499
5 EX-4.3 d852107dex43.htm EX-4.3 72503
6 EX-4.4 d852107dex44.htm EX-4.4 39085
7 EX-4.5 d852107dex45.htm EX-4.5 39184
8 EX-4.6 d852107dex46.htm EX-4.6 39228
9 EX-5.1 d852107dex51.htm EX-5.1 10062
10 EX-5.2 d852107dex52.htm EX-5.2 11573
11 GRAPHIC g852107g1031015126475.jpg GRAPHIC 1952
12 GRAPHIC g852107g1031050427565.jpg GRAPHIC 3549
13 GRAPHIC g852107g1031055742584.jpg GRAPHIC 3549
14 GRAPHIC g852107g52g21.jpg GRAPHIC 1718
  Complete submission text file 0001193125-25-262033.txt   966216
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251442783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)